Dramatic Change in Patient With ALS and MG Following Compassionate Use of BrainStorm Cell Therapeutics Inc.'s NurOwn™ Cell Therapy  
7/3/2012 9:39:10 AM

PETACH TIKVA, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI); Israeli Channel 2 TV interviewed today a patient suffering from Myasthenia Gravis (MG) and recently diagnosed with ALS. The patient reported that he has experienced visible improvement in his speech, walking, balance, posture, muscle strength, appetite, digestion, and weight gain following compassionate treatment with BrainStorm’s NurOwn cell therapy.